United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Technology Industry News Are AI agents about to replace startup founders? Feltsense just raised $5.1m to try Feltsense just raised $5.1M to build AI agents that launch startups autonomously. Could this reshape early-stage venture models? Read the full story. byVenkateshFebruary 5, 2026